Sackler Blues: Healing Pain and Addiction

In the spring of 2019, Purdue Pharma and the Sackler Family were facing numerous lawsuits, with more being prepared to file. Considering (and threatening) bankruptcy, they continued to sell Oxycontin for profit, while blaming addiction to their drug on intentional abuse by the addict. Since the mid 1990’s they had been using their considerable wealth and influence to manipulate their regulators to produce a ‘revolutionary’ drug that would change the face of pain for the entire world. Eventually, they would use the same wealth and power to massage the ongoing narrative about painkiller addiction, and when/how to treat it. As early as 2014, internal Purdue Pharma memos detailed their hopes of entering the treatment side of addiction to maximize profit potentials, effectively becoming an “end to end pain provider”. Largely in an effort to get in front of the impending lawsuit dominoes, they eventually began floating the idea in public. Purdue/Sacklers were interested in creating a drug that would counter the effects of opioid addiction. Claiming that they would not profit from developing this necessary and life-saving drug, they aimed to dictate the course of what they had initially set in motion by monopolizing the tragic results of growing addiction domestically and abroad. They did this solely for profit, unwilling to acknowledge their role in the ongoing struggle, while attempting to assume the role of Hero in the fight.

Want to read more?

Subscribe to ourrawmaterial.com to keep reading this exclusive post.

Subscribe Now